Actively Recruiting
Early Inflammatory Bowel Disease Progression
Led by Pontificia Universidad Catolica de Chile · Updated on 2025-01-01
140
Participants Needed
1
Research Sites
194 weeks
Total Duration
On this page
Sponsors
P
Pontificia Universidad Catolica de Chile
Lead Sponsor
F
Fondo Nacional de Desarrollo Científico y Tecnológico, Chile
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to assess the capacity of the gut microbial composition and function to predict the course of IBD during the first year after diagnosis.
CONDITIONS
Official Title
Early Inflammatory Bowel Disease Progression
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients with with at least 3 weeks of gastrointestinal symptoms including diarrhea, rectal bleeding, abdominal pain, tenesmus or urgency
You will not qualify if you...
- Confirmed infectious disease of the gastrointestinal tract
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Pontificia Universidad Catolica of Chile
Santiago, Chile
Actively Recruiting
Research Team
C
Cristian Hernández-Rocha, MD
CONTACT
M
Manuel Álvarez-Lobos, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here